Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Hong Zhang

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Cancer|July 11, 2019
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trialXiao-Jing Du, Xian-Ming Li, Lin-Bo Cai, et al.
Cell Death and Differentiation|January 5, 2021
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's diseaseWen-Dai Bao, Pei Pang, Xiao-Ting Zhou, et al.
Cell Death and Differentiation|April 4, 2024
Correction: Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's diseaseWen-Dai Bao, Pei Pang, Xiao-Ting Zhou, et al.
Science Advances|April 21, 2023
Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's diseaseLan-Ting Zhou, Dan Liu, Hui-Cong Kang, et al.
Protein & Cell|November 27, 2023
Senktide blocks aberrant RTN3 interactome to retard memory decline and tau pathology in social isolated Alzheimer's disease miceHe-Zhou Huang, Wen-Qing Ai, Na Wei, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Cancer|July 11, 2019
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trialXiao-Jing Du, Xian-Ming Li, Lin-Bo Cai, et al.
Cell Death and Differentiation|January 5, 2021
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's diseaseWen-Dai Bao, Pei Pang, Xiao-Ting Zhou, et al.
Cell Death and Differentiation|April 4, 2024
Correction: Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's diseaseWen-Dai Bao, Pei Pang, Xiao-Ting Zhou, et al.
Science Advances|April 21, 2023
Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's diseaseLan-Ting Zhou, Dan Liu, Hui-Cong Kang, et al.
Protein & Cell|November 27, 2023
Senktide blocks aberrant RTN3 interactome to retard memory decline and tau pathology in social isolated Alzheimer's disease miceHe-Zhou Huang, Wen-Qing Ai, Na Wei, et al.
Pageof 7